[1. Rattner, A. Nathans J. Macular Degeneration: Recent Advances and Therapeutic Opportunities. Nat Rev eurosci. 2006,7(11):860-72.10.1038/nrn2007]Search in Google Scholar
[2. Haddad S, Chen CA, Santangelo SL, Seddon JM. The Genetics of Age-Related Macular Degeneration: A Review of Progress to Date. Surv Ophthalmol. 2006;51(4):316-63.10.1016/j.survophthal.2006.05.001]Search in Google Scholar
[3. Age-Related Eye Disease Study Research Group. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No 8. Arch Ophthalmol. 2001; 119(10):1417-36.10.1001/archopht.119.10.1417]Search in Google Scholar
[4. Klein R, Klein BE, Linton KL. Prevalence of Age-Related Maculopathy. The Beaver Dam Eye Study. Ophthalmology, 1992, 99(6), 933-43.10.1016/S0161-6420(92)31871-8]Search in Google Scholar
[5. Friedman DS, O’Colmain BJ, Muсoz B, Tomany SC, McCarty C, de Jong PTVM, et al. Eye Diseases Prevalence Research Group. Prevalence of Age-Related Macular Degeneration in the United States. Arch Ophthalmol. 2004; 122(4):564-72.10.1001/archopht.1941.00870100042005]Search in Google Scholar
[6. Augood CA, Vingerling JR, de Jong PTVM, Chakravarthy U, Seland J, Soubrane G, et al. Prevalence of Age-Related Maculopathy in Older Europeans: The European Eye Study (EUREYE). Arch Ophthalmol. 2006;124(4):529-35.10.1001/archopht.124.4.52916606879]Search in Google Scholar
[7. Chen Y, Bedell M, Zhang K. Age-Related Macular Degeneration: Genetic and Environmental Factors of Disease. Mol Interv. 2010;10(5):271-81.10.1124/mi.10.5.4300221821045241]Search in Google Scholar
[8. Campochiaro PA. Ocular Neovascularisation and Excessive Vascular Permeability. Expert Opin Biol Ther. 2004;4(9):1395-402.10.1517/14712598.4.9.139515335307]Search in Google Scholar
[9. Fine SL, Berger JW, Maguire MG, Ho AC. Age-Related Macular Degeneration. N Engl J Med. 2000;342:483-92.10.1056/NEJM20000217342070710675430]Search in Google Scholar
[10. Kijlstra A, La Heij E, Hendrikse F. Immunological Factors in the Pathogenesis and Treatment of Age-Related Macular Degeneration. Ocul Immunol Inflamm. 2005;13(1):3-11.10.1080/0927394059090918515804763]Search in Google Scholar
[11. Klein R, Peto T, Bird A, Vannewkirk MR. The Epidemiology of Age-Related Macular Degeneration. Am J Ophthalmol. 2004; 137(3):486-95.10.1016/j.ajo.2003.11.069]Search in Google Scholar
[12. McConnell V, Silvestri G. Age-Related Macular Degeneration. Ulster Med J. 2005;74(2):82-92.]Search in Google Scholar
[13. Bok, D. Evidence for an Inflammatory Process in Age-Related Macular Degeneration Gains New Support. Proc Natl Acad Sci U S A. 2005; 102(20):7053-4.10.1073/pnas.0502819102]Search in Google Scholar
[14. Kuehn BM. Gene Discovery Provides Clues to Cause of Age-Related Macular Degeneration. JAMA. 2005;293(15):1841-5.10.1001/jama.293.15.1841]Search in Google Scholar
[15. Loduca AL, Zhang C, Zelkha R, Shahidi M. Thickness Mapping of Retinal Layers by Spectral Domain Optical Coherence Tomography. Am J Ophthalmol. 2010;150(6);849-55.10.1016/j.ajo.2010.06.034]Search in Google Scholar
[16. Huang J, Liu X, Wu Z, Xiao H, Dustin L, Sadda S. Macular Thickness Measurements in Normal Eyes with Time Domain and Fourier Domain Optical Coherence Tomography. Retina. 2009;29(7):980-7.10.1097/IAE.0b013e3181a2c1a7]Search in Google Scholar
[17. Early Treatment Diabetic Retinopathy Study Design and Baseline Patient Characteristics. ETDRS Report Number 7. Ophthalmology. 1991;98(5 Suppl):741-56.10.1016/S0161-6420(13)38009-9]Search in Google Scholar
[18. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, et al. Clinical Risk Factors for Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. BMC Ophthalmol. 2010;10:31.10.1186/1471-2415-10-31300961921144031]Search in Google Scholar
[19. Bressler SB, Mucoz B, Solomon SD, West SK, Salisbury Eye Evaluation (SEE) Study Team. Racial Differences in the Prevalence of Age-Related Macular Degeneration: The Salisbury Eye Evaluation (SEE) Project. Arch. Ophthalmol. 2008;126(2):241-5.]Search in Google Scholar
[20. Yehoshua Z, Wang F, Rosenfeld PJ, Penha FM, Feuer WJ, Gregori G. Natural History of Drusen Morphology in Age-Related Macular Degeneration Using Spectral Domain Optical Coherence Tomography. Ophthalmology. 2011;118(12):2434-41.10.1016/j.ophtha.2011.05.008318942621724264]Search in Google Scholar
[21. Gregori G, Wang F, Rosenfeld PJ, Yehoshua Z, Gregori NZ, Lujan BJ, et al. Spectral Domain Optical Coherence Tomography Imaging of Drusen in Nonexudative Age-Related Macular Degeneration. Ophthalmology. 2011; 118(7):1373-9.10.1016/j.ophtha.2010.11.013312949321388687]Search in Google Scholar